Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |